دورية أكاديمية

[Long-term efficacy of integrative medicine for treatment of systemic lupus erythematosus].

التفاصيل البيبلوغرافية
العنوان: [Long-term efficacy of integrative medicine for treatment of systemic lupus erythematosus].
المؤلفون: Liu W; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin. fengshiliuwei@163.com, Liu XY, Zhang HB
المصدر: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine [Zhongguo Zhong Xi Yi Jie He Za Zhi] 2009 Mar; Vol. 29 (3), pp. 219-21.
نوع المنشور: English Abstract; Journal Article; Randomized Controlled Trial
اللغة: Chinese
بيانات الدورية: Publisher: Gai yan jiu yuan Country of Publication: China NLM ID: 9211576 Publication Model: Print Cited Medium: Print ISSN: 1003-5370 (Print) Linking ISSN: 10035370 NLM ISO Abbreviation: Zhongguo Zhong Xi Yi Jie He Za Zhi Subsets: MEDLINE
أسماء مطبوعة: Publication: Beijing : Gai yan jiu yuan
Original Publication: Beijing : Gai yan jiu yuan, 1992-
مواضيع طبية MeSH: Integrative Medicine* , Phytotherapy*, Drugs, Chinese Herbal/*therapeutic use , Lupus Erythematosus, Systemic/*drug therapy , Prednisone/*therapeutic use, Adolescent ; Adult ; Aged ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
مستخلص: Objective: To investigate the long-term efficacy of integrative medicine in treating systemic lupus erythematosus (SLE).
Methods: Adopting randomized grouping method, the SLE patients were assigned to two groups, 74 in each group, the treatment group treated by combined hormonotherapy with Chinese drugs for detoxifying, and the control group treated by hormonotherapy alone. The period of the stable phase and active phase, clinical manifestations, 24-h urinary protein, systemic lupus erythematosus disease activity index (SLEDAI) score and complement 3 (C3), etc. were observed.
Results: After 5-year treatment, the clinical manifestations, including arthritis, hydrohymenitis and fever revealed between groups were significantly different (P < 0.05). Comparison between groups in the 5th year of observation showed that the treatment group had a longer time of the stable phase (305.41 +/- 14.32 days); lower SLEDAI scores (8.28 +/- 4.12) and 24-h urinary protein (0.18 +/- 0.01)g, and a higher level of C3 (0.98 +/- 0.35 g/L) than those in the control group (190.22 +/- 15.43 days, 12.79 +/- 5.43 scores, 0.31 +/- 0.06 g and 0.73 +/- 0.34 g/L), respectively, with statistical significances (P < 0.05). Adverse reactions occurred in 15 cases in the treatment group and 62 cases in the control group, also with significant difference between groups (P < 0.05).
Conclusion: The combined therapy of Chinese and Western medicine can prolong the stable phase time and shorten the lasting period of SLE in patients, which embodies the view of "treating disease before its onset".
المشرفين على المادة: 0 (Drugs, Chinese Herbal)
VB0R961HZT (Prednisone)
تواريخ الأحداث: Date Created: 20090625 Date Completed: 20100603 Latest Revision: 20161018
رمز التحديث: 20231215
PMID: 19548437
قاعدة البيانات: MEDLINE